Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6264929 | 1.00 | GAA (0.31) | GAAL3MBTL1RECQL | |
| SCHEMBL6264931 | 1.00 | GAA (0.31) | GAAL3MBTL1RECQL | |
| Cyclopentane SCHEMBL30958867 | 0.97 | KDM4E (0.30) | — | |
| SCHEMBL17696314 | 0.90 | — | — | |
| SCHEMBL16449946 | 0.90 | — | — | |
| SCHEMBL23742008 | 0.90 | — | — | |
| SCHEMBL13150731 | 0.86 | KCNA5 (0.33) | GAAL3MBTL1RECQL | |
| SCHEMBL6265198 | 0.86 | — | — | |
| SCHEMBL6390335 | 0.86 | — | — | |
| SCHEMBL6390108 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11577233-B2 | Monocarbonyl ruthenium and osmium catalysts | Universita' Delgi Studi Di Udine (IT) | 2023-02-14 | — | — | US | disclosed |
| US-20220168720-A1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIV DEGLI STUDI UDINE (IT) | 2022-06-02 | — | — | US | disclosed |
| US-20210107929-A1 | DICARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIVERSITA' DEGLI STUDI DI UDINE AND INNOVATION FACTORY S.R.L. (IT) | 2021-04-15 | — | — | US | disclosed |
| EP-3411347-B1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIV DEGLI STUDI UDINE (IT) | 2021-03-31 | — | — | EP | disclosed |
| US-10301337-B2 | Process | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2019-05-28 | — | — | US | disclosed |
| US-20180170954-A1 | Process | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2018-06-21 | — | — | US | disclosed |
| US-9932362-B2 | Processes for the preparation of ruthenium or osmium complexes comprising P and N donor ligands | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2018-04-03 | — | — | US | disclosed |
| WO-2017134620-A1 | DICARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIVERSITA' DEGLI STUDI DI UDINE (IT) | 2017-08-10 | — | — | WO | disclosed |
| WO-2017134618-A1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | UNIVERSITA' DEGLI STUDI DI UDINE (IT) | 2017-08-10 | — | — | WO | disclosed |
| US-20170081350-A1 | PROCESSES FOR THE PREPARATION OF RUTHENIUM OR OSMIUM COMPLEXES COMPRISING P AND N DONOR LIGANDS | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2017-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10301337-B2 | Process | OSTC, EXOSC9, OGA | GAA 3865/4885L3MBTL1 4701/4885RECQL 2842/4885 |
| US-20170081350-A1 | PROCESSES FOR THE PREPARATION OF RUTHENIUM OR OSMIUM COMPLEXES COMPRISING P AND N DONOR LIGANDS | OSTC, POP1, OGA | GAA 4704/4885L3MBTL1 4487/4885RECQL 1158/4885 |
| US-20220168720-A1 | MONOCARBONYL RUTHENIUM AND OSMIUM CATALYSTS | OTC, CBR3, IDH2 | GAA 4525/4885L3MBTL1 3237/4885RECQL 3518/4885 |
| US-20210107929-A1 | DICARBONYL RUTHENIUM AND OSMIUM CATALYSTS | OTC, ODC1, CBR3 | GAA 4061/4885L3MBTL1 2973/4885RECQL 1408/4885 |
| US-20180170954-A1 | Process | OSTC, EXOSC9, OGA | GAA 3865/4885L3MBTL1 4701/4885RECQL 2842/4885 |
| US-11577233-B2 | Monocarbonyl ruthenium and osmium catalysts | OTC, CBR3, IDH2 | GAA 4525/4885L3MBTL1 3237/4885RECQL 3518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.